Top insider buys: Oct 17 – Oct 23, 2022

The largest open-market purchases company insiders reported on SEC Form 4 between Oct 17 – Oct 23, 2022.

Week 42, 2022

#CompanyWho boughtSharesValueSource
1CABA

Cabaletta Bio, Inc.

2 officers/directors

Cluster buy

Mark Simon, Steven Nichtberger

266,873

$263K

SEC filings
2AZZ

AZZ INC

2 officers/directors

Cluster buy

Kurt L. Russell, Philip A. Schlom

6,000

$210K

SEC filings
3ETNB

89bio, Inc.

Director

RA CAPITAL MANAGEMENT, L.P.

1,172,741

$9.0M

SEC filings
4GRX.C

Gabelli Healthcare & WellnessRx Trust

Director

Mario J. Gabelli

280,000

$3.3M

SEC filings
5GIM

TEMPLETON GLOBAL INCOME FUND

2 separate filers

Saba Capital Management, L.P., FRANKLIN RESOURCES INC

781,706

$3.2M

SEC filings
6GDL.E

GDL FUND

Director

Mario J. Gabelli

200,000

$2.0M

SEC filings
7IMRA

IMARA Inc.

10% Owner

RA CAPITAL MANAGEMENT, L.P.

506,197

$1.9M

SEC filings
8MGNX

MACROGENICS INC

10% Owner

Target N. Biotech V

454,399

$1.8M

SEC filings
9GGZ.B

Gabelli Global Small & Mid Cap Value Trust

Director

Mario J. Gabelli

158,554

$1.6M

SEC filings
10EMO

ClearBridge Energy Midstream Opportunity Fund Inc.

10% Owner

Saba Capital Management, L.P.

42,203

$1.2M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.